Next Article in Journal
Pretargeted Imaging with Gallium-68—Improving the Binding Capability by Increasing the Number of Tetrazine Motifs
Next Article in Special Issue
Can the Efficacy of [18F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
Previous Article in Journal
TRP Channels as Drug Targets to Relieve Itch
Previous Article in Special Issue
Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency
 
 
Review

Article Versions Notes

Pharmaceuticals 2018, 11(4), 101; https://doi.org/10.3390/ph11040101
Action Date Notes Link
article xml file uploaded 11 October 2018 10:25 CEST Original file -
article xml uploaded. 11 October 2018 10:25 CEST Update https://www.mdpi.com/1424-8247/11/4/101/xml
article pdf uploaded. 11 October 2018 10:25 CEST Version of Record https://www.mdpi.com/1424-8247/11/4/101/pdf
article html file updated 11 October 2018 10:26 CEST Original file -
article html file updated 26 December 2018 23:35 CET Update -
article html file updated 1 April 2019 04:33 CEST Update -
article html file updated 14 April 2019 16:36 CEST Update -
article html file updated 28 April 2019 21:27 CEST Update -
article html file updated 8 October 2019 21:47 CEST Update -
article html file updated 10 February 2020 15:11 CET Update -
article html file updated 17 July 2022 04:37 CEST Update https://www.mdpi.com/1424-8247/11/4/101/html
Back to TopTop